Alzheimer's Association International Conference 2020

The Alzheimer's Association International Conference, held virtually from July 27-31, 2020m is where international investigators, clinicians and care providers gather to share the latest study results, theories, and discoveries that will help bring the world closer to breakthroughs in dementia science.
The director of the Memory Disorders Program and professor of neurology at Georgetown University Medical Center detailed the phase 2 study findings of nilotinib in patients with Alzheimer disease.
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed her study presented at AAIC 2020 that examined Alzheimer risk associated with  APOE ε4  in different genetic populations.